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Background: Advanced pellucid marginal degeneration is a debilitating disease that war-
rants the use of surgery when the visual acuity is reduced and contact lenses are not tolerated
anymore. It is traditionally managed with corneal transplantation, however alternative surgi-
cal options exist. Corneal wedge resection allows for good visual rehabilitation without the
risks of tissue rejection. However topographical and refractive results are in some instance
fluctuating. We present here the use of corneal cross-linking in order to stabilize the
parameters on the long term.
Case presentation: We present here the case of a 53 years old patient with bilateral advanced
pellucid marginal degeneration. As he is now intolerant to contact lenses a surgical option is
offered to him. In order to avoid using donated tissue through corneal grafting we decide to
perform a sectorial lamellar crescentric wedge excision of the thinner inferior part of the cornea
involving the pellucidmarginal degeneration and suture it. The first eye shows initial good results
however after few months regression is observed. The second eye is then treated with the same
surgical technique combined with cornea cross-linking. Long-term follow-up shows stabilization
and absence of regression in the second eye up to eight months after the surgery.
Conclusion: Combining corneal cross-linking with corneal wedge resection in the case of
advanced pellucid marginal degeneration patients could be a good option in order to stabilize
topographical and refractive results and reduces the risk of regression.
Keywords: cornea, ectasia, pellucid marginal degeneration, cornea cross-linking, wedge
resection
Introduction
Pellucid marginal degeneration (PMD) is a rare non-inflammatory corneal ectatic
disorder that is characterized by progressive peripheral corneal thinning. The
disease progression can induce irregular astigmatism leading sometimes to reduced
visual acuity. PMD is distinctive in its features from keratoconus in the way that
there is a crescent-shaped inferior band of corneal thinning with associated ectasia
and the disease is usually diagnosed in an older set of patients with a male
predilection.1 Some cases of PMD can overlap keratoconus and typical patterns
such as “crab-claws” or “kissing birds” patterns can be seen in both diseases as
initially described. Modern topographical measurement devices such as
Scheimpflug imaging allow us to distinguish now crab-claw patterns in PMD-like
keratoconus from rarer true PMD disease. Reduced visual acuity can be initially
compensated by contact lenses such as rigid gas permeable or scleral contact lenses.
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However when those fail to provide adequate correction
due to significant astigmatism or are not tolerated any-
more, surgery can be considered. Standard surgical man-
agement usually includes penetrating keratoplasty or deep
anterior lamellar keratoplasty. Nonetheless the peripheral
inferior thinning and steepening of the cornea moderates
the success of such surgery. Marked irregular astigmatism
can be induced by suturing the graft to a thin peripheral
tissue and larger grafts that could overcome this issue
present a larger risk of graft rejection.2 Thus the alterna-
tive surgical option of crescentric corneal wedge resection
has been proposed some years ago with good results on
visual rehabilitation and sparring the use of donated cor-
neal tissue. However in some cases topographical regres-
sion is observed with consecutive reduced visual acuity.3,4
Methods
We present here the case of a patient treated on the first
eye with the already described procedure that later on
presented topographical regression and treated for the sec-
ond eye with a combination of surgery and corneal cross-
linking to stabilize refractive and topographical results.
Case Presentation
A 53 years old gentleman was referred to our Ophthalmology
department for progressive bilateral pellucid marginal degen-
eration. He was known for a previous benign traumatic
corneal abrasion in his right eye 14 years ago with no other
relevant ocular history. He was previously fitted with scleral
contact lenses with good visual improvement however he
later stopped using them as he experienced intolerance
despite multiple trials. He has been followed with corneal
topography that demonstrated progressive increase in astig-
matism over the past year.
At his first clinical examination uncorrected for dis-
tance visual acuity (UDVA) was 0.05 (decimal) in the right
eye and counting fingers in the left eye. Corrected for
distance visual acuity (CDVA) was 0.08 in the right eye
with −3.00 −5.25/76° and 0.08 in the left eye with −11.75
−7.50/160°. Slit lamp examination showed mild posterior
blepharitis, bilateral clear corneas with visible inferior
protrusion and associated thinning with an otherwise
quiet and deep anterior chamber. Intraocular pressure was
9mmHg in both eyes with non-contact measurements,
crystalline lens had no signs of cataract bilaterally, and
fundus examination was within normal limits.
Keratometric readings were obtained from Scheimpflug
imaging (Pentacam, Oculus, Optikgeräte GmbH, Wetzlar,
Germany) in both eyes. Both topographies showed PMD
patterns with the steepest anterior point inferiorly displaced
with associated thinning and irregular astigmatism on ante-
rior sagittal maps (Figures 1A and 2A). Anterior segment
optical coherence tomography (AS-OCT) (Optovue, Inc.,
Freemont, CA) confirmed the inferior thinning in both eyes
with a thinnest measurement of 341μm in the right eye and
270μm in the left eye.
As the patient reported reduced vision bilaterally with
markedly reduced quality of life and presented persisting
contact lens intolerance despite numerous trials, a surgical
option was offered in order to improve the patient’s visual
acuity. Instead of a penetrating keratoplasty or a deep
anterior lamellar keratoplasty we decided to perform a
sectorial lamellar crescentric wedge resection of the thin-
ner inferior part of the cornea and suture it. Risks and
benefits were explained to the patient, consent obtained
and the surgery was scheduled under general anesthesia.
The left eye was prepped and draped in a sterile man-
ner. The epithelium was removed with a hockey stick
inferiorly over the thinner crescentric part of the cornea.
One side port was created at 2 o’clock and a cohesive
viscoelastic was injected in the anterior chamber in order
to maintain a stable chamber in case of perforation. A
circular blade was used to create a crescentric incision
on the lower part of the cornea starting from 9 o’clock
up to 3 o’clock. The cornea was then dissected as close as
possible to the Descemet membrane and the crescentric
dissection was then excised. The superior corneal margin
of the excised tissue was then pulled down and sutured
with seven interrupted 10–0 nylon sutures to the lower
margin. The viscoelastic was removed and an antibiotic
ointment was added with an eyepad.
On the following day examination, his UDVA in the left
eye had improved to 0.5 and the CDVA to 0.6. Slit-lamp
examination showed a clear central cornea. The peripheral
inferior cornea showed tight sutures and no residual thinning.
The rest of the slit-lamp examination was within normal
limits and intraocular pressure was 10mmHg in the right
eye and 7mmHg in the left eye. The corneal astigmatism
was also regularizedwith regular oblique astigmatism pattern
on the anterior sagittal map with 10.9D at 52° axis. The
thinnest pachymetry on Scheimpflug imaging had improved
to 470 μm (Figure 1B).
The patient was followed monthly with topography and
early signs of regression were evident in his second month
follow up in comparison to first month. Four months after-
wards and following corneal sutures removal, the patient
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reported an improvement in his vision: UDVA is 0.5 and
improves to 1.0 with refraction. The anterior sagittal topo-
graphical pattern on topography is however more irregular
at this follow-up showing regression of the treatment with
marked steepening inferiorly and loss of regular pattern
(Figure 1C). Ten months after the surgery the patient’s left
eye UDVA has then reduced to 0.05 improving to 0.2
CDVA. On scheimpflug imaging the anterior sagittal map
showed recurring irregular astigmatism with inferior
marked steepening (Figure 1D).
The second eye was planned for surgery two months
after the first one. As early signs of regression were
observed at the two months examination on the first eye
topography it was decided to perform again a corneal
wedge resection and combine it with corneal cross-linking
in order to stabilize postoperative results and reduce the
risk of regression. Surgery was performed in the right eye
similarly as described above for the left eye. At the end of
the surgery an epithelium-off corneal cross-linking was
performed with 9mw/cm2 for 10 mins (5.4mJ/cm2
Figure 1 Scheimpflug-based corneal topography of the left eye (OS). (A) Preoperatively, demonstrating PMD pattern with inferior steepening associated with thinning and
irregular astigmatism on the anterior sagittal map. (B) At day one following crescentic corneal wedge resection, showing regularization of the corneal astigmatism. (C) Four
months postoperatively, showing marked steepening inferiorly. (D) Ten months postoperatively, showing recurring irregular astigmatism in the anterior sagittal map
coinciding with inferior steepening and a minimum corneal thickness of 387μm.
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fluence) settings. Corneal thickness at the area of the
suturing was measured with ultrasound pachymetry prior
to irradiation and thinnest measurement was 435μm. The
epithelium was removed on the inferior half of the cornea
involving the disease beforehand. The irradiation circle
included the area of the suturing. Postoperative care was
similar as for the first eye.
Four days after the surgery the UDVA was 0.5. Treated
cornea showed tight sutures, a healing epithelial defect with-
out any sign of infection and within normal limits intraocular
pressure. Topographical patterns were regularized with now
oblique 3.7D anterior astigmatism at 25° (Figure 2B). One
month postoperatively demarcation line depth was measured
at 250μm. Sutures were removed up to 4 months postopera-
tively. Eight months after the surgery UDVA is 0.25 and
improves to 0.6 CDVA on refraction. Scheimpflug imaging
shows a stable regularized anterior pattern within the 4.5mm
central cornea with 2.3D astigmatism, inferiorly a mild stee-
pening is present (Figures 2C, 3A and B). At the 14th post-
operative month visit, his CDVA remained 0.6 and corneal
topography demonstrated a stable pattern in comparison to
previous follow up visits.
Discussion
Several surgical options exist to treat pellucid marginal
degeneration.5 Penetrating keratoplasty as well as deep ante-
rior lamellar keratoplasty are widely used ones in advanced
cases and aim to restor visual acuity through reduction of
corneal astigmatism with donated tissue. Corneal cross-link-
ing has been used for the stabilization of the disorder either
alone or combined with laser ablation for the imrovement of
visual acuity.6,7 Studies demonstrate efficacy of the techni-
que for halting progression although there is a lack of large
series with long term follow up. Lately, sliding keratoplasty
in combination with cross-linking has also been presented.8
Corneal wedge resection was initially described by Durand
et al in 1991 as an alternative to treat pellucid marginal
degeneration.4 However, this sectoral crescentric removal
of the diseased tissue has only been described in a limited
number of reports in the litterature.9–11 Sectoral removal of
the abnormal ectatic tissue is a useful surgical approach that
permits to reduce or even avoid complications linked to
grafted tissue such as rejection, primary or secondary failure
and glaucoma. Furthermore, the superiorly located “healthy”
corneal tissue is pulled down towards the central visual axis
and reduces the overall corneal astigmatism through this
“face-lift” of the cornea and excision of the thinned patholo-
gical tissue.12 Cornea remodeling and wound healing takes
place after the surgery and induces progressive changes in
corneal topography. Selective suture removal can help shap-
ing this corneal remodelling in order to stabilize or improve
topographical changes before achieving refractive stability.
In some instance however topographical instability and
regression of the treatment will take place despite good initial
surgical outcome and following management.2,3
Figure 2 Scheimpflug-based corneal topography of the right eye (OD). (A) Preoperatively, demonstrating PMD pattern with inferior steepening associated with thinning and
irregular astigmatism on the anterior sagittal map. (B) Four days following combined corneal wedge resection and corneal cross-linking, showing regularization of the
topographic pattern. (C) Eight months postoperatively, depicting a stable regularized anterior pattern with mild inferior steepening and a thinnest pachymetry of 452μm.
Figure 3 Post-operative slit-lamp photography of anterior segment of the right eye
with broad illumination (A) and with slit illumination from side view (B).
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In our case the visual acuity improved quickly after the
surgery of the first eye at day one associated with regular-
ization of the corneal astigmatism on topography.
However two months after the surgery early irregular
changes were observed on the topography. Despite an
overrall improved topography compared to preoperative
measurements, the visual acuity was reduced at the ten
months follow-up with partial regression of the treatment
visible on Scheimpflug imaging. Rigid contact lenses can
help to partially compensate the recurring irregular astig-
matism. In our case however this was not an option as the
patient was intolerant to contact lenses. Corneal cross-
linking was thus successfully used to help stabilize corneal
healing in the second eye with good refractive and topo-
graphical outcomes.
Corneal cross-linking is nowadays used as the standard
of care to stabilize progressive ectatic disorders such as
keratoconus with good long-term outcomes.13,14 It has
since then been used for several other purposes such as
infectious keratitis or more recently in donor tissue for
penetrating keratoplasties. In the later, results in animal
and human model showed both that surgically induced
astigmatism is reduced postoperatively.15,16 In the rando-
mized controlled trial by Huang and colleagues patient’s
with cross-linked donated corneas showed significantly
improved visual acuity, lesser degree of spherical equiva-
lent, lower Kmax and keratometric astigmatism compared
to the non cross-linked group at three years follow-up.16
Interestingly Mukherjee et al reported also significant
improvement in their animal experiment.15 Furthermore
in a letter to the editor their group also proposed that the
significant reduced higher-order aberrations observed in
the animal cross-linked group could explain the improved
visual acuity reported in the human study; however these
parameters were not measured in the later study.
A possible limitation of the presented method is the
questionable efficacy of corneal crosslinking in advanced
cases of ectasia, such as those cases of pellucid marginal
degeneration that are suitable for wedge resection. Other
options other than grafting or wedge resection are suitable
for earlier cases that can be combined with CXL.
Nevertheless, this report showcases good results that a
large series with long term follow up would be necessary
to prove.
Conclusion
In contact-lens intolerant patients this surgery is a good
alternative to more invasive ones such as penetrating
keratoplasty or deep anterior lamellar surgery. A quick
visual recovery can be expected as the healthy tissue is
pulled within the central visual axis and allows good
visual rehabilitation in patients with otherwise poor visual
acuity. According to our results we propose here that the
stiffening effect of corneal cross-linking helps also to
stabilize topographical and refractive results and reduces
the risk of regression in a deep anterior crescentric wedge
excision for advanced pellucid marginal degeneration as it
can do it for penetrating keratoplasties.
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